ZBH - Zimmer Biomet Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
119.37
+1.25 (+1.06%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close118.12
Open118.04
Bid119.56 x 1000
Ask119.41 x 900
Day's Range117.71 - 120.02
52 Week Range96.99 - 134.55
Volume1,114,499
Avg. Volume1,162,481
Market Cap24.447B
Beta (3Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.96 (0.84%)
Ex-Dividend Date2019-03-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investors are overly pessimistic, now is the time buy: Investment strategist
    CNBC Videos2 months ago

    Investors are overly pessimistic, now is the time buy: Investment strategist

    Jeff Krumpelman, chief investment strategist and head of equities at Mariner Wealth Advisors, and Kenny Polcari, managing principal at Butcher Joseph Asset Management, join CNBC's "The Exchange" to discuss mid-day markets and the stocks they're watching.

  • Zimmer Biomet Grows Internationally Despite Pricing Pressure
    Zacks7 days ago

    Zimmer Biomet Grows Internationally Despite Pricing Pressure

    Zimmer Biomet (ZBH) witnesses strength in the EMEA and APAC regions as well as in the Spine & CMF business.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about Zimmer Biomet Holdings Inc.

    Zimmer Biomet Holdings Inc NYSE:ZBHView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ZBH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZBH. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold ZBH had net inflows of $3.63 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Is Zimmer Biomet Holdings Inc (ZBH) A Good Stock To Buy?
    Insider Monkey13 days ago

    Is Zimmer Biomet Holdings Inc (ZBH) A Good Stock To Buy?

    At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of March 31. In this […]

  • Why Is Zimmer (ZBH) Down 8.2% Since Last Earnings Report?
    Zacks25 days ago

    Why Is Zimmer (ZBH) Down 8.2% Since Last Earnings Report?

    Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • MoneyShowlast month

    Buckingham's Bets- Two Values in Healthcare

    First quarter corporate report cards generally have been good, with 75% or so of S&P; 500 companies beating earnings estimates, observes John Buckingham, value investing expert and editor of The Prudent Speculator.

  • GuruFocus.comlast month

    Jeff Auxier Comments on Zimmer Biomet

    Guru stock highlight

  • GuruFocus.comlast month

    Jeff Auxier's 1st Quarter Auxier Focus Fund Shareholder Letter

    The Fed made a material reversal at year-end and lower interest rates have fueled gains for both stocks and bonds. Unprecedented technological innovation is driving impressive productivity gains which has helped to keep inflation in check. Where socialism grows so does inflation and stagnation.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ZBH earnings conference call or presentation 26-Apr-19 12:30pm GMT

    Q1 2019 Zimmer Biomet Holdings Inc Earnings Call

  • Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript

    ZBH earnings call for the period ending March 31, 2019.

  • Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates
    Zacks2 months ago

    Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates

    While sales in Americas remains dull, Zimmer Biomet (ZBH) is witnessing strength in the Asia Pacific and EMEA regions.

  • Zimmer Biomet Holdings Sales and Earnings Slip in Q1
    Motley Fool2 months ago

    Zimmer Biomet Holdings Sales and Earnings Slip in Q1

    The musculoskeletal healthcare company continues to try to turn things around, with limited success in the first quarter.

  • Associated Press2 months ago

    Zimmer: 1Q Earnings Snapshot

    On a per-share basis, the Warsaw, Indiana-based company said it had net income of $1.20. Earnings, adjusted for one-time gains and costs, came to $1.87 per share. The results surpassed Wall Street expectations. ...

  • Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?
    Zacks2 months ago

    Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?

    With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.

  • Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline
    Zacks2 months ago

    Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline

    Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • T Rowe Price Equity Income Fund Buys 6 Stocks in 1st Quarter
    GuruFocus.com2 months ago

    T Rowe Price Equity Income Fund Buys 6 Stocks in 1st Quarter

    Top buys include Conagra and Fox spinoff

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ZBH earnings conference call or presentation 1-Feb-19 1:30pm GMT

    Q4 2018 Zimmer Biomet Holdings Inc Earnings Call

  • Were Hedge Funds Right About Zimmer Biomet Holdings Inc (ZBH)?
    Insider Monkey3 months ago

    Were Hedge Funds Right About Zimmer Biomet Holdings Inc (ZBH)?

    Zimmer Biomet Holdings Inc (NYSE:ZBH) investors should be aware of a decrease in hedge fund sentiment in recent months. Zimmer Biomet Holdings Inc (ZBH) was in 36 hedge funds' portfolios at the end of the fourth quarter of 2018. There were 40 hedge funds in our database with ZBH positions at the end of the previous […]

  • Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings
    Zacks3 months ago

    Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

    With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

  • Zimmer Biomet Solid on Global Prospects Despite Price Pressure
    Zacks3 months ago

    Zimmer Biomet Solid on Global Prospects Despite Price Pressure

    Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.

  • RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio
    Zacks3 months ago

    RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

    RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

  • Zacks3 months ago

    Stocks Slide for Third Straight Day

    Stocks Slide for Third Straight Day